Sagimet Biosciences Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $56.7M |
| FY2022 | $5.4M | $33.0M | $158.0K |
| FY2023 | $5.7M | $96.7M | $75.1M |
| FY2024 | $4.5M | $160.3M | $75.8M |
| FY2025 | $5.1M | $116.5M | $35.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $56.7M |
| FY2022 | $5.4M | $33.0M | $158.0K |
| FY2023 | $5.7M | $96.7M | $75.1M |
| FY2024 | $4.5M | $160.3M | $75.8M |
| FY2025 | $5.1M | $116.5M | $35.0M |